(Q39675372)

13 September 2017

1 reference

title

Clinical consequences of abrupt drug withdrawal (English)

1 reference

13 September 2017

C F George

1

1 reference

13 September 2017

D Robertson

series ordinal

2

1 reference

13 September 2017

publication date

1 September 1987

1 reference

Medical toxicology and adverse drug experience

13 September 2017

published in

1 reference

13 September 2017

volume

2

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

367-382

1 reference

Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Coronary artery syndromes after sudden propranolol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

A study of the mechanism of the steroid withdrawal syndrome. Evidence for integrity of the hypothalamic-pituitary-adrenal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Certain endocrine and metabolic facets of the steroid withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal from long-term high-dose desipramine therapy. Clinical and biological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal from Glucocorticoid Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Neuroleptic-induced supersensitivity psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

The adrenal cortex in internal medicine. I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

21 January 2018

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Detoxification of rehabilitated methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

PROBABILITIES OF PITUITARY-ADRENAL RESPONSIVENESS AFTER STEROID THERAPY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Diazepam withdrawal syndrome: a case with psychosis, seizure, and coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

The treatable epilepsies. (First of Two Parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

EEG lateral asymmetries in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Arterial pressure responses to discontinuing antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Chronic barbiturate intoxication: further studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Degree of physical dependence induced by secobarbital or pentobarbital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Abrupt propranolol withdrawal in angina pectoris: Effects on platelet aggregation and exercise tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal syndromes associated with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Panic anxiety after abrupt discontinuation of amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Clonidine withdrawal. Mechanism and frequency of rebound hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Clonidine blocks acute opiate-withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Clinical management of benzodiazepine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Persistence of Extra-pyramidal Disorders and Psychiatric Relapse after Withdrawal of Long-Term Phenothiazine Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Lorazepam withdrawal seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Failure of labetalol to prevent hypertension due to clonidine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

21 January 2018

Abuse of barbiturates.

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Clinical characteristics of addictions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Tolerance and addiction liability of 6-dimethylamino-4-4-diphenylheptanone-3 (methadon).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Alterations of Glucocorticoid Actions by Other Drugs and Disease States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Frequency of recurrence after discontinuance of anticonvulsant therapy in patients with epileptic seizures: a new follow-up study after 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Psychological Dependency on Steroids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal symptoms from lithium. Four case reports and a questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Propranolol withdrawal and thyroid hormones in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Medical effects of abrupt neuroleptic withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal symptoms after graduated cessation of imipramine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Case report of withdrawal dyskinesia associated with amoxapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

21 January 2018

Diuretic-induced oedema

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Benzodiazepine Withdrawal Syndrome: A Literature Review and Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal symptoms after six weeks' treatment with diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Propranolol withdrawal in angina pectoris: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Propranolol and polythiazide in treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Depression following withdrawal from long-term benzodiazepine use: a report of four cases

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF03259954

21 January 2018

12 December 2020

Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Increased dopamine-receptor sensitivity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Benzodiazepine Dependence A Review of the Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Abrupt cessation of high-dose imipramine treatment in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Abrupt withdrawal from therapeutically administered diazepam. Report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Letter: Withdrawal symptoms after stopping phenelzine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Benzodiazepines and withdrawal psychosis. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Pharmacological advances in addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Cardiovascular Drug Withdrawal Syndromes A Potential Problem with Calcium Antagonists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal Syndrome Following Cessation of Guanabenz Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Multiple Mechanisms of withdrawal from Opioid Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Chronic Antiepileptic Toxicity: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Use of labetalol in hypertensive patients during discontinuation of clonidine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Major status epilepticus. A series of 42 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Delirium after abrupt withdrawal from doxepin: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Imipramine withdrawal: an akathisia-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Altered hemoglobin-oxygen affinity with long-term propranolol therapy in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Letter: Rebound hypertension after acute methyldopa withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Propranolol rebound—A retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Adrenal suppression after short-term corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

A review of medication errors and compliance in ambulant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Pituitary adrenal recovery following short-term suppression with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Gradual withdrawal of diazepam after long-term therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Benzodiazepine withdrawal symptoms and propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Abrupt cessation of treatment with centrally acting antihypertensive agents. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Trasicor in Angina Pectoris: a Double-blind Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

Infant of the addicted mother

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259954

STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN

21 January 2018

1 reference

12 December 2020

Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment

1 reference

12 December 2020

Benzodiazepines--a challenge to rational prescribing

1 reference

12 December 2020

Lithium withdrawal triggers psychosis

1 reference

12 December 2020

Abrupt cessation of clonidine administration: a prospective study

1 reference

12 December 2020

Hypomania and mania after withdrawal of tricyclic antidepressants

1 reference

12 December 2020

Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists

1 reference

12 December 2020

Recovery of adrenal function after substitution of beclomethasone dipropionate for oral corticosteroids.

1 reference

12 December 2020

Rebound hypertension after acute methyldopa withdrawal

1 reference

12 December 2020

Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity

1 reference

12 December 2020

Management of pituitary-adrenal suppression secondary to corticosteroid therapy

1 reference

12 December 2020

Difficulty in stopping lithium prophylaxis?

1 reference

12 December 2020

Withdrawal reactions from chlordiazepoxide ("Librium")

1 reference

12 December 2020

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

1 reference

12 December 2020

Lithium withdrawal triggers psychotic states

1 reference

12 December 2020

PSEUDOTUMOR CEREBRI ASSOCIATED WITH PROLONGED CORTICOSTEROID THERAPY. REPORTS OF FOUR CASES.

1 reference

12 December 2020

The over-shoot phenomenon on withdrawal of clonidine therapy

1 reference

12 December 2020

Discontinuing antiepileptic medication in children with epilepsy after two years without seizures. A prospective study

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents

1 reference

12 December 2020

The glucocorticoid withdrawal syndrome

1 reference

12 December 2020

Psychosis after neuroleptic withdrawal in a manic-depressive patient

1 reference

12 December 2020

Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence

1 reference

12 December 2020

Withdrawal from long-term benzodiazepine treatment

1 reference

12 December 2020

Rebound phenomenon during gradual withdrawal of clonidine

1 reference

12 December 2020

Evaluation of standard anticonvulsant therapy in three hundred nineteen patients

1 reference

12 December 2020

Practolol in treatment of angina pectoris. A double-blind trial

1 reference

12 December 2020

Some problems with benzodiazepines

1 reference

12 December 2020

Epilepsy and employment

1 reference

12 December 2020

Postoperative adrenal cortical insufficiency; occurrence in patients previously treated with cortisone

1 reference

12 December 2020

The phenomenon of ?-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects

1 reference

12 December 2020

Diagnosis and Treatment of Drug Dependence of the Barbiturate Type

1 reference

12 December 2020

Glucocorticoid therapy.

1 reference

12 December 2020

The effects of non-prescribing of anxiolytics in general practice. I. Controlled evaluation of psychiatric and social outcome

1 reference

12 December 2020

Withdrawal symptoms during the course of imipramine therapy

1 reference

12 December 2020

Prognosis in childhood epilepsy. Follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control

1 reference

12 December 2020

Remission of Seizures and Relapse in Patients with Epilepsy

1 reference

12 December 2020

Adverse effects of antiparkinson drug withdrawal

1 reference

12 December 2020

Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents

1 reference

12 December 2020

Antidepressant withdrawal phenomena

1 reference

12 December 2020

Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris

1 reference

12 December 2020

Cortisone Habituation — A Clinical Note

1 reference

12 December 2020

Fatal exacerbation of systemic lupus erythematosus after treatment with griseofulvin

1 reference

12 December 2020

Withdrawal symptoms following dicontinuation of imipramine therapy

1 reference

12 December 2020

Committee on the Review of Medicines. Recommendations on barbiturate preparations

1 reference

12 December 2020

Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline

1 reference

12 December 2020

Treatment of clonidine rebound syndrome with sublingual captopril

1 reference

12 December 2020

Central nervous system actions of clonidine in hypertension

1 reference

12 December 2020

Rapid recurrence of mania following lithium withdrawal

1 reference

12 December 2020

Medical treatment in epilepsy

1 reference

12 December 2020

Metoprolol withdrawal phenomena: mechanism and prevention

1 reference

12 December 2020

Opposite Effects of Captopril on Angiotensin I-Converting Enzyme ‘Activity’ and ‘Concentration’; Relation between Enzyme Inhibition and Long-Term Blood Pressure Response

1 reference

12 December 2020

Drug withdrawal syndromes-- a literature review

1 reference

12 December 2020

Effects of gradual decrease and discontinuation of neuroleptics on clinical condition and tardive dyskinesia [proceedings]

1 reference

12 December 2020

Benzodiazepines on trial

1 reference

12 December 2020

Death due to withdrawal of barbiturates

1 reference

12 December 2020

Experimental Withdrawal of Lithium in Recovered Manic-Depressive Patients: A Report of Five Cases

1 reference

12 December 2020

Withdrawal symptoms after long-term treatment with low-potency neuroleptics

1 reference

12 December 2020

A cross-national comparison of anti-anxiety/sedative drug use.

1 reference

12 December 2020

Antidepressant withdrawal symptoms treated with anticholinergic agents.

1 reference

12 December 2020

Identification and management of benzodiazepine dependence

1 reference

12 December 2020

Epileptic seizures in a population of 6000. II: Treatment and prognosis

1 reference

12 December 2020

Blood pressure and heart rate and withdrawal of antihypertensive drugs

1 reference

12 December 2020

Clinical experience with chlorothiazide (diuril), with particular emphasis on untoward responses; a report of 121 cases studied over a 15 month period

1 reference

12 December 2020

Neonatal Barbiturate Withdrawal

1 reference

12 December 2020

Clonidine in outpatient detoxification from methadone maintenance

1 reference

12 December 2020

DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS

1 reference

12 December 2020

A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II)

1 reference

12 December 2020

Propranolol in angina pectoris

1 reference

12 December 2020

Adverse effects of drugs in later pregnancy

1 reference

12 December 2020

Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure

1 reference

12 December 2020

Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension

1 reference

12 December 2020

Benzodiazepine withdrawal: an unfinished story

1 reference

12 December 2020

Withdrawal symptoms after abrupt cessation of amitriptyline in an eight-year-old boy

1 reference

12 December 2020

Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol

1 reference

12 December 2020

Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects

1 reference

12 December 2020

Benzodiazepines in general practice: time for a decision

1 reference

12 December 2020

Stopping medication in children with epilepsy: predictors of outcome

1 reference

12 December 2020

Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03259954

1 reference

13 September 2017

1 reference